Aging, Reperfusion, and Apoptosis:A Proteasome Approach

衰老、再灌注和细胞凋亡:蛋白酶体方法

基本信息

  • 批准号:
    6743130
  • 负责人:
  • 金额:
    $ 19.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-05-01 至 2005-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant) Complications arising from reduction of blood supply to the heart are a leading cause of death and debilitation worldwide. Depending on the duration and severity of the ischemic event, irreparable alterations in cellular homeostasis lead to necrotic cell death. However, reperfusion of viable cardiac tissue can result in cell death by processes unrelated to necrosis. This has been attributed, in part, to increases in the production of oxygen radicals and the induction of programmed cell death, termed apoptosis. The proteasome, a major intracellular proteolytic system, appears to play a critical role in the prevention of apoptosis by degrading certain pro-apoptotic factors. Nevertheless, the proteasome is itself modified by free radical processes and exhibits dramatic declines in activity as a result of coronary occlusion/reperfusion. Furthermore, proteasome expression and specific activity decrease as a function of age. The objectives of the proposed research are to establish a mechanistic link between age and free radical induced loss in proteasome function and stimulation of the apoptotic process during coronary occlusion/reperfusion. Utilizing a physiologically relevant in vivo rat model of coronary occlusion and reperfusion this study seeks to: 1) Identify alterations in proteasome activity; 2) Defme free radical processes which result in loss in proteasome activity; 3) Characterize the progression of apoptosis; and 4) Establish mechanisms by which proteasome inactivation enhances apoptosis. In each aim, the effects of duration of occlusion and reperfusion and age of the animal will be assessed. Thus, these studies will establish biochemical mechanisms by which proteasome function is altered and when, in the sequence of coronary occlusion and reperfusion, critical oxidative events occur. Furthermore, the role of proteasome inactivation in the induction of apoptosis will be established. Finally, the contribution of age-dependent declines in proteasome activity to the progression and extent of coronary occlusion/reperfusion induced apoptosis will be elucidated. Results of the proposed study will therefore define molecular events which are likely to impact the long term progression of heart disease and indicate efficient strategies for favorably influencing the outcome.
描述:(申请人提供)因复位引起的并发症 心脏的血液供应是导致死亡和虚弱的主要原因。 全世界。根据缺血事件的持续时间和严重程度, 细胞动态平衡的不可修复的改变会导致坏死性细胞死亡。 然而,存活的心脏组织的再灌流可通过以下方式导致细胞死亡 与坏死无关的过程。这在一定程度上归因于 氧自由基产生的增加和程序化的诱导 细胞死亡,称为细胞凋亡。蛋白酶体,一种主要的细胞内蛋白水解物 系统,似乎在防止细胞凋亡中起着关键作用 降解某些促凋亡因子。然而,蛋白酶体本身就是 被自由基过程修饰,活性急剧下降 冠脉闭塞/再灌注的结果。此外,蛋白酶体 随着年龄的增长,其表达和比活性降低。目标 拟议的研究的一部分是在年龄和年龄之间建立一种机械联系 自由基致蛋白酶体功能丧失及对细胞的刺激作用 冠状动脉闭塞/再灌流过程中的细胞凋亡过程。利用一种 与生理相关的大鼠冠状动脉闭塞在体模型 再灌流本研究试图:1)确定蛋白酶体的改变 活性;2)导致蛋白酶体丢失的清除自由基过程 活性;3)表征细胞凋亡的进程;以及4)建立 蛋白酶体失活促进细胞凋亡的机制。在每个目标中, 脑缺血再灌流时间和动物年龄的影响 被评估。因此,这些研究将建立生化机制,通过 蛋白酶体功能发生改变时,在冠状动脉闭塞的顺序中 和再灌注时,会发生严重的氧化事件。此外,中国的作用是 蛋白酶体失活在诱导细胞凋亡中的作用将被确立。 最后,与年龄相关的蛋白酶体活性下降对 冠状动脉闭塞/再灌注诱导细胞凋亡的进展及程度 将会被澄清。因此,拟议研究的结果将界定 可能影响心脏长期进展的分子事件 疾病,并指出有效的战略,以有利地影响 结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LUKE I. SZWEDA其他文献

LUKE I. SZWEDA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LUKE I. SZWEDA', 18)}}的其他基金

Diversity Supplement-Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
多样性补充-氧化DNA损伤调节心肌细胞增殖
  • 批准号:
    9898738
  • 财政年份:
    2018
  • 资助金额:
    $ 19.47万
  • 项目类别:
Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
DNA 氧化损伤调节心肌细胞增殖
  • 批准号:
    9921473
  • 财政年份:
    2018
  • 资助金额:
    $ 19.47万
  • 项目类别:
Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
DNA 氧化损伤调节心肌细胞增殖
  • 批准号:
    9752677
  • 财政年份:
    2018
  • 资助金额:
    $ 19.47万
  • 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
  • 批准号:
    6478574
  • 财政年份:
    2002
  • 资助金额:
    $ 19.47万
  • 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
  • 批准号:
    6625766
  • 财政年份:
    2002
  • 资助金额:
    $ 19.47万
  • 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
  • 批准号:
    7020621
  • 财政年份:
    2002
  • 资助金额:
    $ 19.47万
  • 项目类别:
Modulation of Mitochondrial Function by Pro-Oxidants
促氧化剂对线粒体功能的调节
  • 批准号:
    7897640
  • 财政年份:
    1999
  • 资助金额:
    $ 19.47万
  • 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
  • 批准号:
    2743533
  • 财政年份:
    1999
  • 资助金额:
    $ 19.47万
  • 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
  • 批准号:
    6626440
  • 财政年份:
    1999
  • 资助金额:
    $ 19.47万
  • 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
  • 批准号:
    6488849
  • 财政年份:
    1999
  • 资助金额:
    $ 19.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了